The use of molecular descriptors in the development of co-amorphous formulations

Meng-Lund, Helena; Kasten, Georgia; Jensen, Katrine Tarp; Poso, Antti; Pantsar, Tatu; Rades, Thomas; Rantanen, Jukka; Grohganz, Holger

dc.contributor.author	Poso, Antti
dc.date.accessioned	2019-09-10T11:37:57Z
dc.date.available	2019-09-10T11:37:57Z
dc.date.issued	2018
dc.identifier.issn	1879-0720
dc.identifier.uri	http://hdl.handle.net/10900/92602
dc.language.iso	en	de_DE
dc.publisher	Elsevier Science Bv	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejps.2018.04.014	de_DE
dc.subject.ddc	610	de_DE
dc.title	The use of molecular descriptors in the development of co-amorphous formulations	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_02160
utue.publikation.seiten	31-38	de_DE
utue.personen.roh	Meng-Lund, Helena
utue.personen.roh	Kasten, Georgia
utue.personen.roh	Jensen, Katrine Tarp
utue.personen.roh	Poso, Antti
utue.personen.roh	Pantsar, Tatu
utue.personen.roh	Rades, Thomas
utue.personen.roh	Rantanen, Jukka
utue.personen.roh	Grohganz, Holger
dcterms.isPartOf.ZSTitelID	European Journal of Pharmaceutical Sciences	de_DE
dcterms.isPartOf.ZS-Volume	119	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE